Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies for serious medical conditions such as cancer and metabolic diseases. The company also focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. It will develop novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health. Petra Pharma was founded in 2016 and is headquartered in New York, USA.

Hefei Boscochuang Pharmaceutical Technology Co., Ltd., established on 2006-05-11, Business scope includes food,medicine,cosmetic,medical instruments,Sanitation Products,medical supplements,pet medicine,Diagnostic reagents,Experimental Instruments and Consumables,Pharmaceutical Intermediates(In addition to the above hazardous chemicals)research and development,Production,Sales;Medical related technical consultation,Technical Services,technology transfer;Self-operated and agent import and export business of various commodity technologies(Except for commodities and technologies restricted or prohibited by national laws and regulations);Computer hardware and software,cyber security,Cloud Computing Technology Development,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS). AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

Solae LLC (which traded as The Solae Company) was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Asahi Kasei Chemicals Corp. manufactures organic and industrial chemicals. It provides coating materials, latexes, pharmaceutical and food additives, explosives, photopolymers and platemaking systems, separation and ion-exchange membranes, cling film, storage bags, plastic film, sheet, and foam. The company is headquartered in Tokyo, Japan.

Your B2B Partner for Innovation in Health, Wellbeing, Cosmetics and Life Science Over 20 years of experience in the production and use of Ectoin® and other extremolytes makes bitop a valuable and trustworthy partner for the pharmaceutical, cosmetics, and life science industries.

Shandong fuyang Biotechnology Co., Ltd. is a high-tech enterprise mainly engaged in the R&D, manufacture, sales and trade of sodium gluconate,Gluco-delta-lactone(GDL), trehalose modified starch, gluconic acid and corn starch, which have all been approved by ISO9001, ISO22000,KOSHER,HALAL and HACCP. Featuring technology, innovation and development, we have established excellent market image. The annual output is 150,000tons,6,000Tons,5,000Tons 50,000tons, 7,000Tons and 300,000tons.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

ORTHOReBIRTH is a medical device sales and distribution company. The company produces and markets orthopedic biologics that improve patients'​ quality of life and offer superior outcomes. ORTHOReBIRTH U brings premium orthopedic biologics to surgeons practicing around the world. The company aims to decrease any burden, physically and mentally of both patients and doctors by creating innovative medical apparatus in the field of orthopedics. ORTHOReBIRTH was founded in June 2011 and is headquartered in Georgetown, Texas.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.